Life settlement provider vs broker due diligence for accredited investors 2026: the 4-row role differentiation + 5-point intermediary DD framework.

Provider and broker occupy distinct positions in life settlement market structure with critically different legal duties and investor relevance. Life settlement PROVIDER: Buyer-side intermediary that purchases policies from policy owners (directly or through broker intermediation); provides institutional capital for policy acquisition; may hold policies in portfolio or resell to accredited investors; state-licensed under provider framework per NAIC Model Act #697 or NCOIL Life Settlements Model Act readopted October 2024; owes NO fiduciary duty to accredited investor buyer; is counterparty to investor transaction, not fiduciary advocate. Life settlement BROKER: Seller-side intermediary that represents policy owner in marketing policy to multiple providers; executes competitive bid process on owner's behalf; receives compensation typically as percentage of transaction value or structured fee; state-licensed under broker framework per NCOIL/NAIC Model Acts; OWES statutory fiduciary duty to policy owner to act in owner's best interest regardless of compensation structure per Massachusetts §213(7) and equivalent state statutes; required to disclose compensation methodology and amount to owner. For accredited investor significance: investors interact directly with providers during policy acquisition process, NOT with brokers. Broker fiduciary duty protects original policy owner (typically unsophisticated elderly individual) but provides no direct protection to accredited investor buyer. Investor buyer-side intermediary DD must focus on provider counterparty verification using 5-point framework (state licensing, Model Act compliance, E&O + surety bond, fee transparency, track record + regulatory history). Broker quality affects investor only indirectly through chain-of-title documentation review during Component 05 Legal/Structural DD per Day 114 framework.

Provider licensing verification requires multi-source cross-reference across state insurance regulator databases, industry association resources, and provider-supplied documentation. Step 1 — Identify required licensing jurisdictions: Provider must be licensed in states where (a) policy was issued, (b) insured currently resides, and (c) provider operates. For most transactions, this means 2-5 state verifications per deployment. Step 2 — Access state insurance regulator databases: Each state insurance department maintains public licensing lookup accessible through state website. Search by provider name and verify: current license status (active/inactive), license number, license effective date, any pending disciplinary actions or enforcement proceedings. Step 3 — ELSA Licensed Provider Matrix Q3 2026 cross-reference: European Life Settlement Association publishes quarterly Licensed Provider Matrix compiling publicly available state licensing data plus provider self-certification. Matrix accessible through ELSA website (elsa-sls.org). Matrix lists licensed providers by state with X denoting full life settlement license, V denoting viatical-only license. Cross-reference provider claimed licensing jurisdictions against ELSA matrix for third-party verification. Step 4 — Non-licensing state analysis: ELSA Q3 2026 confirms 6 jurisdictions do not currently require provider licensing: Alabama, District of Columbia, Missouri, South Carolina, South Dakota, and Wyoming. For transactions involving these states, standard licensing verification unavailable; alternative verification mechanisms (ELSA matrix inclusion, industry association membership, E&O carrier underwriting willingness, principal background) become more important. Step 5 — Provider documentation review: Request certificates of licensing from provider directly; verify match with state regulator records; document receipt date and verification date for compliance file. Step 6 — Document findings: Create intermediary DD file documenting licensing verification methodology, sources accessed, findings per state, and any irregularities identified. Standard institutional DD timeline: 3-5 business days for standard 2-5 state verification; 7-10 business days for complex multi-state verification. HYV coordinates provider licensing verification across platform-presented positions as component of institutional service.

NCOIL and NAIC each publish model acts governing life settlement regulation, with states choosing which framework (or hybrid) to adopt. The two frameworks differ in material respects affecting both policy owner protection and investor regulatory environment. NCOIL Life Settlements Model Act: Published and periodically updated by National Conference of Insurance Legislators (NCOIL). Most recent re-adoption: October 2024. Key provisions: 2-year minimum holding period between policy issuance and life settlement sale eligibility; broker fiduciary duty to owner regardless of compensation structure; state licensing framework for providers and brokers; fraud prevention provisions; E&O coverage requirements. Adopted by: approximately 25+ US states including Delaware, Texas (with amendments), Florida (with STOLI exception additions), and others. NAIC Viatical Settlements Model Act #697: Published by National Association of Insurance Commissioners (NAIC); originally 1993, revised 2003, 2004, and 2007 (STOLI additions). Key provisions: 5-year minimum holding period between policy issuance and life settlement sale eligibility (vs NCOIL's 2 years); broker fiduciary duty provisions (similar to NCOIL); STOLI-specific provisions added 2007; disclosure requirements for alternatives to settlement; rescission rights. Adopted by: approximately 20+ US states including Massachusetts (with 2-year amendment), New York (with modifications), California (with amendments). Hybrid adoptions: Many states adopted elements of both frameworks with state-specific amendments producing complex multi-framework landscape. Framework divergence significance for investor DD: Holding period variance affects which policies qualify for secondary market sale eligibility — important for understanding chain-of-title timing and valid acquisition rights; disclosure requirements variance affects documentation available during Component 05 Legal/Structural DD; provider licensing framework variance affects multi-state compliance analysis for Component DD.2 intermediary verification. Standard practice: investor DD should verify which Model Act framework applies in specific policy jurisdiction and confirm provider demonstrated compliance with applicable framework. Specialized state-by-state compliance analysis required for complex multi-jurisdictional transactions.

The fiduciary duty asymmetry reflects deliberate regulatory architecture distinguishing consumer-protective transactions (where unsophisticated parties need statutory protection) from sophisticated-counterparty transactions (where parties are presumed capable of independent protection). The provider-investor relationship falls in the second category under current regulatory framework. Regulatory rationale: Policy owners selling their policies through life settlements are typically elderly individuals (average age 70+) with limited financial literacy and significant information asymmetry with institutional buyers. The broker fiduciary duty framework protects owners by requiring their intermediary to prioritize owner interests over broker compensation; this framework compensates for owner inability to execute independent DD on complex insurance transactions. Accredited investors buying from providers are presumed sophisticated: minimum $1M net worth or $200K/$300K annual income per SEC Rule 501 definition; typically experienced in alternative investments; capable of engaging legal, tax, and insurance advisors; expected to execute independent due diligence on counterparty quality. The regulatory framework does not provide equivalent statutory protection because accredited investor status presupposes capability to self-protect through independent DD. Practical investor implication: Investor cannot assume provider will act in investor's best interest beyond contractual obligations in purchase agreement; investor must execute independent 5-point intermediary DD framework to verify provider counterparty quality before deployment; investor should review purchase agreement terms including representations and warranties, indemnification provisions, closing conditions, and post-closing obligations with experienced counsel; investor should maintain ongoing provider monitoring during multi-year holding period for regulatory status changes, financial condition changes, or operational discontinuities. The absence of statutory fiduciary duty is not a defect in the regulatory framework but a design feature reflecting investor sophistication expectations. Rigorous investor-side intermediary DD is the appropriate response to this framework design.

Track record and regulatory history (Component DD.5 Critical) represents the strongest leading indicator of forward provider counterparty quality. Comprehensive track record investigation covers these dimensions. Business operational history: 10+ years continuous operations preferred as established market participant; 5-10 years acceptable with other strong indicators; less than 5 years warrants elevated scrutiny particularly if principals lack prior industry experience. AUM and transaction volume: Material AUM ($100M+) and transaction count (100+ transactions executed) indicate operational scale and market acceptance; small AUM may indicate either boutique focus or market acceptance challenges requiring investigation. State enforcement actions: Search all states where provider is licensed for current or historical enforcement actions, consent orders, cease and desist actions, license suspensions, or civil penalties; any material regulatory action warrants investigation of underlying circumstances and resolution; clean regulatory record across all operating jurisdictions is the standard institutional expectation. Consumer complaint history: Access state insurance regulator consumer complaint databases where available; evaluate complaint volume relative to transaction volume; investigate pattern of complaints (categorical issues vs isolated events). Principal background: Investigate founding principals and current senior leadership backgrounds including prior industry experience, prior business entity relationships, FINRA BrokerCheck records if applicable, SEC enforcement history if applicable, and any disciplinary actions by professional licensing boards. Litigation history: Review commercial litigation history for pattern of disputes or material adverse findings; routine commercial disputes are normal; litigation pattern suggesting operational quality issues warrants investigation. Industry participation: Active membership in Institutional Life Markets Association (ILMA) with voting status, European Life Settlement Association (ELSA), Life Insurance Settlement Association (LISA) indicates industry acceptance and provides peer-review structure; absence of industry participation warrants investigation of reasons. M&A and principal transition history: Mergers, acquisitions, or principal transitions within past 5 years warrant separate analysis of predecessor track record vs current entity capability. Red flags: Enforcement actions resulting in material penalties or license suspensions; principal background including prior fraud findings or industry bar; pattern of consumer complaints with regulatory action; material litigation indicating operational quality issues; absence from industry associations or ELSA Licensed Provider Matrix. HYV internal DD includes comprehensive Component DD.5 track record analysis for all platform-presented provider counterparties.

The ELSA Licensed Provider Matrix is a quarterly-published authoritative verification resource maintained by the European Life Settlement Association (ELSA) that compiles publicly available state licensing data plus provider self-certification into single reference matrix accessible through the ELSA website (elsa-sls.org). The matrix serves as third-party verification source complementing but not replacing direct state insurance regulator database verification. Matrix structure: Grid format with providers listed as rows and US states listed as columns; cells indicate licensing status with X denoting full life settlement license, V denoting viatical-only license (narrower scope than full life settlement license), and blank denoting no licensing (or state does not require licensing). Data sources per ELSA documentation: state insurance regulator websites or report services such as NAIC State-Based System platform; direct public records requests to state regulators where reporting unavailable; provider self-certification confirmation of matrix entries. Publication cadence: Quarterly updates with current matrix as of August 2026 for Q3 2026 publication. Non-licensing states: Matrix identifies 6 jurisdictions not currently requiring provider licensing: Alabama (AL), District of Columbia (DC), Missouri (MO), South Carolina (SC), South Dakota (SD), and Wyoming (WY). Investor verification methodology: Step 1 — identify provider claimed licensing jurisdictions from provider marketing materials or direct inquiry. Step 2 — cross-reference claimed jurisdictions against ELSA matrix entries. Step 3 — verify matrix entries against direct state regulator database searches for authoritative confirmation. Step 4 — document any discrepancies between provider claims, matrix entries, and state database findings. Step 5 — resolve discrepancies through direct communication with provider or state regulator as needed. Matrix limitations: Matrix reflects point-in-time data as of publication; recent licensing changes may not be reflected until next quarterly update; viatical-only licensing (V) does not authorize full life settlement transactions and requires understanding of scope distinction; matrix does not include detailed regulatory history or enforcement action information requiring separate state regulator database access. Best practice: use ELSA matrix as efficient cross-reference verification tool but always confirm key findings through direct state insurance regulator database access particularly for primary operating jurisdictions. HYV coordinates ELSA matrix cross-reference verification as standard component of platform intermediary DD process.